NY S05169 | 2019-2020 | General Assembly
Status
Spectrum: Partisan Bill (Democrat 11-0)
Status: Introduced on April 12 2019 - 25% progression, died in committee
Action: 2020-02-05 - PRINT NUMBER 5169A
Pending: Senate Consumer Affairs and Protection Committee
Text: Latest bill text (Amended) [HTML]
Status: Introduced on April 12 2019 - 25% progression, died in committee
Action: 2020-02-05 - PRINT NUMBER 5169A
Pending: Senate Consumer Affairs and Protection Committee
Text: Latest bill text (Amended) [HTML]
Summary
Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.
Title
Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.
Sponsors
History
Date | Chamber | Action |
---|---|---|
2020-02-05 | Senate | PRINT NUMBER 5169A |
2020-02-05 | Senate | AMEND (T) AND RECOMMIT TO CONSUMER PROTECTION |
2020-01-08 | Senate | REFERRED TO CONSUMER PROTECTION |
2019-04-12 | Senate | REFERRED TO CONSUMER PROTECTION |
Same As/Similar To
A07196 (Same As) 2020-02-05 - print number 7196a